Fluconazole use and birth defects in the National Birth Defects Prevention Study
- 1 May 2016
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 214 (5) , 657.e1-657.e9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Use of Oral Fluconazole during Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2013
- Use of Antiepileptic Medications in Pregnancy in Relation to Risks of Birth DefectsAnnals of Epidemiology, 2011
- Prevalence at Birth of Cleft Lip with or without Cleft Palate: Data from the International Perinatal Database of Typical Oral Clefts (IPDTOC)The Cleft Palate Craniofacial Journal, 2011
- Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006Birth Defects Research Part A: Clinical and Molecular Teratology, 2010
- Fluconazole alters CYP26 gene expression in mouse embryosReproductive Toxicology, 2009
- Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort studyJournal of Antimicrobial Chemotherapy, 2008
- Antifungal drugs and the risk of selected birth defectsAmerican Journal of Obstetrics and Gynecology, 2008
- Prenatal exposure to fluconazole: An identifiable dysmorphic phenotypeBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Fluconazole teratogenicityPrenatal Diagnosis, 1998
- CONGENITAL MALFORMATIONS IN AN INFANT BORN TO A WOMAN TREATED WITH FLUCONAZOLEThe Pediatric Infectious Disease Journal, 1992